“…This approach leads to distinct possibilities, including the development of new cardiac tissue engineering strategies, through the use of decellularized/recellularized organs in transplants, as well as allowing the characterization of the cardiac ECM in normal or pathological conditions. Over the last 10 years, different decellularization and recellularization strategies were developed and performed with murine (Ott et al, 2008; Carvalho et al, 2012; Lu et al, 2013; Wang et al, 2019), porcine (Ott et al, 2008; Weymann et al, 2014; Ferng et al, 2017; Lee P.-F. et al, 2017), bovine (Arslan et al, 2018) and even human (Sánchez et al, 2015; Garreta et al, 2016; Guyette et al, 2016) heart tissue (revised by Scarrit et al, 2015; Tang-Quan et al, 2018).…”